BioSpace News Archive

Pharm Country

KaliVir Immunotherapeutics Announces Presentation at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

KaliVir Immunotherapeutics, Inc. today announced that its Director of Immunology, Ravikumar Muthuswamy , Ph.D., will present " Novel Oncolytic therapy VET3-TGI restricts TGFβ1 and augments Type-1 immune response in TME, in an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting.

May 3, 2023
·
2 min read
Business

Ginkgo Bioworks Announces Date of First Quarter 2023 Results Presentation

Ginkgo Bioworks today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2023.

May 3, 2023
·
1 min read
Hovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry Powder Inhalation formulation delivery

Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart’s Sunriser© Capsule-based Dry Powder Inhaler platform.

May 3, 2023
·
4 min read
Pharm Country

Avantor® to Participate in BofA Securities 2023 Health Care Conference

Avantor, Inc. announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the BofA Securities 2023 Health Care Conference in Las Vegas on Tuesday, May 9, 2023 at approximately 8:00 a.m. Pacific Time.

May 3, 2023
·
1 min read
Pharm Country

Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy

Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy.

May 3, 2023
·
19 min read
Business

GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023

GlycoMimetics, Inc. today reported its financial results and highlights for the first quarter ended March 31, 2023.

May 3, 2023
·
6 min read
Business

Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors

Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors.

May 3, 2023
·
4 min read
Business

Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results

Deciphera Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.

May 3, 2023
·
14 min read
Business

Curve Biosciences Appoints Industry Veterans to Leadership Team, Announces Commercial Advisory Board

Curve Biosciences Appoints Industry Veterans to Leadership Team, Announces Commercial Advisory Board.

May 3, 2023
·
6 min read
Lone Star Bio

Study Demonstrates Use of DecisionDx®-Melanoma to Guide Treatment Decisions Resulted in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients Without Surveillance Imaging Studies

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent, multi-center study in the Archives of Dermatological Research providing a direct chain of evidence that use of DecisionDx®-Melanoma test results to guide radiological surveillance could lead to improved patient outcomes.

May 3, 2023
·
8 min read